Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 163

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 163
---
 bear a Rule 144 legend.

On
June 10, 2025, the Company approved the grant of 250,000 options pursuant to the Company’s 2023 Equity Incentive Plan to a consultant
for services to be rendered under a consulting agreement. The exercise price of the options is $0.67 per share, with 25% of the options
vesting immediately and the remainder vesting ratably on a monthly basis, commencing on July 31, 2025 and ending on May 31, 2027. The
options expire ten years after the grant date.

On
July 2, 2025, the Compensation Committee approved the grant of an aggregate of 357,448 stock options issued to certain executives. The
stock options have an exercise price of $1.19 per share, representing the closing price of the Company’s Common Stock on the Nasdaq on the date of grant. The stock options have a 10 year term and vest in equal installments over a three (3) year period
beginning on the grant date of July 2, 2025, subject to the officers’ continued employment at the time of vesting.

On
September 5, 2025, the Company granted an aggregate of 374,755 stock options to two consultants with an exercise price of $1.23 per share
and a grant date fair value of $340,900. The stock options have a 10 year term and 25% of the stock options vest immediately on the grant date, with 281,066
options vesting in equal monthly installments until September 5, 2027. The Company also granted 109,902 stock options to one of the consultants
with an exercise price of $1.23 per share and a grant date fair value of $82,427, and a 10 year term that vest solely upon achievement
of performance conditions as follows: (a) 15% per Ambassador (maximum of three) referred by consultant and subsequently engaged by the
Company, (b) 20% if consultant is instrumental in arranging a distribution arrangement not previously pursued by the Company, on terms
acceptable to the Company, (c) 20% when such Distribution Contract achieves $1 million in annual sales and (d) 15% when the consultant
arranges the first Celebrity Golf Tournament featuring Nugevia on terms and conditions acceptable to the Company.

On
July 16, 2025 the Company entered